Doug Speake

– Doug Speake has worked in Edinburgh for 5 years having trained in Manchester. He is an honorary senior lecturer with the University of Edinburgh and an NHS research Scotland Clinician.
– Currently, sits on the National Cancer Research Institute colorectal subcommittee.
– Doug’s special interest is in the management of the earliest type of bowel cancer and how best to manage this.
– Publications; Five-year oncological outcomes after selective neoadjuvant radiotherapy for resectable rectal cancer, Jun 2019
Meta-analysis of the effect of perioperative intravenous lidocaine on return of gastrointestinal function after colorectal surgery, Feb 2019 Effect of IV lidocaine on the resumption of gut function after colorectal surgery: a meta-analysis, July 2017